Tropical Islands Resort

Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19

Retrieved on: 
Wednesday, October 4, 2023
COVID-19, Research, Infectious Diseases, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Aerium, Infection, UNC School of Medicine, RBD, Vaccination, Rockefeller University, SARS-CoV-2, Hook effect, Hope, Person, CHUV, Global Health, Death, EPFL, Immunodeficiency, Fred Hutchinson Cancer Research Center, Therapy, Vaccine, ACE2, Lausanne University Hospital, Tropical Islands Resort, Medicine

AER004 was discovered by Michel Nussenzweig at Rockefeller University and also blocks the RBD in a complementary manner to AER003.

Key Points: 
  • AER004 was discovered by Michel Nussenzweig at Rockefeller University and also blocks the RBD in a complementary manner to AER003.
  • Aerium is pursuing a mAb combination strategy to defend against future viral evolution.
  • Aerium is also initiating development of AER005 for potential inclusion in a future product.
  • The mAbs have been modified to provide long-acting protection and exhibit potent and consistent activity against all previous and predominantly circulating variants.

Tubulis Appoints Seasoned ADC Expert Björn Hock as Chief Development Officer

Retrieved on: 
Thursday, February 16, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Aerium, Limited partnership, CDO, Therapy, ADC, Drug development, Patient, Tropical Islands Resort, Merck, Ferring Pharmaceuticals, Spacecraft, Doctor of Philosophy, Management, Biochemistry, Rida al-Tubuly

Tubulis today announced the appointment of Björn Hock, PhD, as Chief Development Officer (CDO) to further strengthen its leadership team with a seasoned drug development expert.

Key Points: 
  • Tubulis today announced the appointment of Björn Hock, PhD, as Chief Development Officer (CDO) to further strengthen its leadership team with a seasoned drug development expert.
  • At Tubulis, he will be responsible for defining preclinical development strategies for the company’s current drug candidates in oncology to rapidly achieve IND-readiness.
  • “We are grateful for his extended commitment in supporting us as Chief Development Officer.
  • Over the course of his career, Dr. Hock has led the successful development of several platform technologies and therapeutic programs from concept to lead candidate stage.

Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats

Retrieved on: 
Tuesday, March 22, 2022
Aerium, Pantaleo, Therapy, Vaccination, DRS, Degenerative disease, Medtech, Leadership, Multimedia, Board, Omega, Health care, Vaccine, Volatile organic compound, EPFL, Research, White, Delta, Capital, Severe acute respiratory syndrome coronavirus 2, Precision medicine, CEO, AstraZeneca, Immunology, Merck & Co., White House, CHUV, Omicron, Technology, Neutralizing antibody, Virology, COVID-19, Trono, Montreux Healthcare Fund, Series, BioRxiv, Bill & Melinda Gates Foundation, FDA, Director, History, Partnership, Antibody, Financial services, Management, Pharmaceutical industry, Medicine, Takeda, Coalition for Epidemic Preparedness Innovations, Pfizer, Ultragenyx, Tropical Islands Resort, Genetics

While we are initially assisting populations vulnerable to COVID-19 in the prophylactic and therapeutic settings, our overall vision is to develop effective therapeutics against not just existing but also future epidemic and pandemic threats."

Key Points: 
  • While we are initially assisting populations vulnerable to COVID-19 in the prophylactic and therapeutic settings, our overall vision is to develop effective therapeutics against not just existing but also future epidemic and pandemic threats."
  • Aerium Therapeutics has assembled a growing team of proven life science and enterprise leaders including:
    CEO Rajeev Venkayya, M.D.
  • Aerium Therapeutics is dedicated to epidemic and pandemic preparedness through the discovery and development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats.
  • The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future.

Blue Water Partners with National Land Lease Capital and Expands into Texas

Retrieved on: 
Monday, January 24, 2022
Organization, Travel, CEO, PORT, Industry, Bluewater, Marketing, Blue Waters Hotel, Multimedia, Contract, Blue, Golf, Water, Partnership, Acquisition, Tourism, Tropical Islands Resort, RV

This partnership both solidifies the recent acquisition of the Port Aransas, Tx., properties and marks the two companies' expansions into Texas.

Key Points: 
  • This partnership both solidifies the recent acquisition of the Port Aransas, Tx., properties and marks the two companies' expansions into Texas.
  • Currently, Blue Water manages over 20 properties all over the country, with the addition of Tropic Island Resort marking its expansion into Texas.
  • Blue Water is slated to continue rapidly expanding its management portfolio nationwide in the years to come with NLLC.
  • Founded by Jack and Todd Burbage in 2002, Blue Water specializes in investing, developing, and managing RV resorts, campgrounds, hotels, and attractions.

Germany's Tropical Islands Resort Welcomes a New Water Play Structure, by Polin Waterparks

Retrieved on: 
Tuesday, March 19, 2019
Amusement parks, Water park, Morey's Piers, Tropical Islands Resort, Water slide, Polin Waterparks

Many of these technologies feature prominently into the slides that Polin included in the Tropical Islands attraction.

Key Points: 
  • Many of these technologies feature prominently into the slides that Polin included in the Tropical Islands attraction.
  • Tropical Islands Resort Europe's largest tropical holiday resort, situated 60km south of Berlin in Krausnick, on the fringes of the Spree Forest.
  • Polin was founded in Istanbul in 1976 and has since grown into a leading company in the waterparks industry.
  • Today Polin is a world leader in the design, production and installation of waterparks, waterslides &and water-play attractions.

Germany's Tropical Islands Resort Welcomes a New Water Play Structure, by Polin Waterparks

Retrieved on: 
Tuesday, March 19, 2019
Amusement parks, Water park, Morey's Piers, Tropical Islands Resort, Water slide, Polin Waterparks

Many of these technologies feature prominently into the slides that Polin included in the Tropical Islands attraction.

Key Points: 
  • Many of these technologies feature prominently into the slides that Polin included in the Tropical Islands attraction.
  • Tropical Islands Resort Europe's largest tropical holiday resort, situated 60km south of Berlin in Krausnick, on the fringes of the Spree Forest.
  • Polin was founded in Istanbul in 1976 and has since grown into a leading company in the waterparks industry.
  • Today Polin is a world leader in the design, production and installation of waterparks, waterslides &and water-play attractions.